The novel walrus Balloon Guide Catheter (BGC) from Q’Apel Medical has received USFDA clearance.
Speed, reliability and performance is very critical in neurovascular space for patient outcomes. That’s why the physicians and patients demand best-in-class innovative technologies.
The walrus BGC, with its 087 ID, is similar best-in-class device in balloon guide catheter technology and for stroke patient worldwide.
The walrus BGC is the second FDA-cleared technology from Q’Apel in the past 12 months, joining wahoo Access Catheter with Selectflex technology in Q’Apel’s expanding product portfolio.
Q’Apel Medical LLC, medical device company, has few other innovative products in line to come to the market over the course of the next year.
Mr Vinod Arora, Principal Advisor, IGMPI
Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like